Insights into the 2025 ESC/EACTS guidelines on the management of patients with valvular heart disease
The 2025 Practice Guidelines on the management of patients with valvular heart disease of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery include new and updated recommendations based on the evidence provided by several landmark randomized clinical tr...
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/225559 |
| Acceso en línea: | https://hdl.handle.net/2445/225559 |
| Access Level: | acceso embargado |
| Palabra clave: | Cardiologia Malalties cardiovasculars Diagnòstic Cardiology Cardiovascular diseases Diagnosis |
| Sumario: | The 2025 Practice Guidelines on the management of patients with valvular heart disease of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery include new and updated recommendations based on the evidence provided by several landmark randomized clinical trials and large multicentre registries (1). How these new recommendations may apply to and impact on current clinical practice in Spain will be discussed in this commentary. |
|---|